Etravirine for HIV-1-infected Patients Failing Antiretroviral Therapy

Etravirine for HIV-1-infected Patients Failing Antiretroviral Therapy

0:00
9 August 2007

&t Margaret Johnson ;em>REFERENCE: Lancet 2007; 370:39-48 MARGARET JOHNSON, Royal Free Hospital, London A new non-nucleoside reverse-transcriptase inhibitor has demonstrated its activity in patie

&t

Margaret Johnson

Margaret Johnson

;em>REFERENCE: Lancet 2007; 370:39-48MARGARET JOHNSON, Royal Free Hospital, LondonA new non-nucleoside reverse-transcriptase inhibitor has demonstrated its activity in patients infected with HIV-1. TMC125, or etravirine, was compared with placebo in over 500 treatment-experienced patients in the DUET-2 trial, and Derek Thorne heard more fromMargaret Johnsonof the Royal Free Hospital in London.